Preclinical News and Research

RSS
Pfizer's PD0325901 experimental drug blocks untreatable NF1 tumors

Pfizer's PD0325901 experimental drug blocks untreatable NF1 tumors

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Acetylon announces results from selective HDAC 1/2 inhibitor preclinical study on SCD and bT

Acetylon announces results from selective HDAC 1/2 inhibitor preclinical study on SCD and bT

Infinity announces new data from IPI-145 Phase 1 trial on advanced hematologic malignancies

Infinity announces new data from IPI-145 Phase 1 trial on advanced hematologic malignancies

Angiocidin reduces acute myeloid leukemia cells in vivo by almost two-thirds in pre-clinical studies

Angiocidin reduces acute myeloid leukemia cells in vivo by almost two-thirds in pre-clinical studies

Perimenopausal lifestyle modifications could reduce risk of breast cancer in obese woman

Perimenopausal lifestyle modifications could reduce risk of breast cancer in obese woman

BlueGenics aims to discover new drugs from deep sea to combat osteoporosis

BlueGenics aims to discover new drugs from deep sea to combat osteoporosis

GSK, MD Anderson partner to develop new therapeutic antibodies against cancer

GSK, MD Anderson partner to develop new therapeutic antibodies against cancer

Advance Study to evaluate safety and benefit of DBS-f for patients with mild Alzheimer's

Advance Study to evaluate safety and benefit of DBS-f for patients with mild Alzheimer's

Naurex reports positive results from GLYX-13 Phase IIa trial on depression

Naurex reports positive results from GLYX-13 Phase IIa trial on depression

Bio-Path to initiate BP-100-1.01 Phase I trial for treatment of two types of breast cancer

Bio-Path to initiate BP-100-1.01 Phase I trial for treatment of two types of breast cancer

Fexinidazole enters Phase II/III clinical study to treat sleeping sickness

Fexinidazole enters Phase II/III clinical study to treat sleeping sickness

Using Nanoparticles to Target Cancer

Using Nanoparticles to Target Cancer

Investigators describe process by which apoE4 protein promotes development of Alzheimer's

Investigators describe process by which apoE4 protein promotes development of Alzheimer's

Scientists evaluate two different strategies to treat Usher syndrome

Scientists evaluate two different strategies to treat Usher syndrome

Moderna Therapeutics closes $40M in financing

Moderna Therapeutics closes $40M in financing

University of Florida initiates enrollment in SPI-1005 Phase II trial for sensorineural hearing loss

University of Florida initiates enrollment in SPI-1005 Phase II trial for sensorineural hearing loss

Nanoparticle-based drug delivery attacks cancer cells without harming normal ones

Nanoparticle-based drug delivery attacks cancer cells without harming normal ones

Researchers investigate GPER receptor as possible new drug target for breast cancer

Researchers investigate GPER receptor as possible new drug target for breast cancer

Natural killer cell response detrimental to glioblastoma virotherapy

Natural killer cell response detrimental to glioblastoma virotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.